Trials / Active Not Recruiting
Active Not RecruitingNCT03906578
Effects of a Probiotic in Hypertension
Effect of a Probiotic on Blood Pressure in Low-to-moderate Risk Grade 1 Hypertension - a Randomized Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
High blood pressure is a major risk factor for cardiovascular events, including stroke, heart and kidney failure. Typical anti-hypertensive drugs target vessels, the kidneys or the heart. Here we propose a randomized, placebo-controlled study to test the blood pressure-lowering effect of a probiotic in 110 patients with grade 1 hypertension. In addition, we will investigate glucose variability, fecal bacterial metabolome, peripheral blood effector T cell frequencies (%) and health-related quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vivomixx® | Microbiotic food supplement with L. paracasei, L. plantarum, L. acidophilus, L. delbrueckii, B. longum, B. infantis, B. breve, S. thermophilus |
| OTHER | Placebo | Placebo with similar appearance to probiotic |
Timeline
- Start date
- 2019-09-02
- Primary completion
- 2024-09-01
- Completion
- 2025-09-01
- First posted
- 2019-04-08
- Last updated
- 2024-07-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03906578. Inclusion in this directory is not an endorsement.